Overview

Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients

Status:
ENROLLING_BY_INVITATION

Trial end date:
2025-05-20

Target enrollment:

Participant gender:

Summary

A Randomized, Double-Blind, Parallel-Group, Exploratory Clinical Study to Evaluate the Safety, Pharmacodynamic Effects, and Pharmacokinetic Characteristics of Multiple Subcutaneous Injections of LP-98 in Treatment-Naive HIV-Infected Individuals

Phase:

PHASE1

Details

Lead Sponsor:

Shanxi Kangbao Biological Product Co., Ltd.

Collaborator:

Chinese Academy of Medical Sciences